Table 4.
Group A | Group B | Group C | Group D | |
---|---|---|---|---|
CD3+ 1 | 1600 | 1620 | 1880 | 1280 |
CD3+ 2 | 1850 | 1750 | 1700 | 1570 |
CD3+ 3 | 1400 | 1480 | 1350 | 900 |
CD3+CD4+ 1 | 900 | 1060 | 1200 | 800 |
CD3+CD4+ 2 | 1050 | 1200 | 1100 | 900 |
CD3+CD4+ 3 | 700 | 880 | 1200 | 450 |
CD3+CD8+ 1 | 600 | 550 | 880 | 500 |
CD3+CD8+ 2 | 780 | 580 | 1100 | 650 |
CD3+CD8+ 3 | 650 | 600 | 620 | 450 |
NK-1 | 300 | 210 | 350 | 200 |
NK-2 | 350 | 280 | 300 | 200 |
NK-3 | 200 | 250 | 200 | 150 |
NKT-1 | 150 | 200 | 190 | 100 |
NKT-2 | 180 | 180 | 250 | 120 |
NKT-3 | 150 | 185 | 160 | 100 |
Notes: group A, chemotherapy alone; group B, chemotherapy and IFN-α; group C, chemotherapy and IFN-γ; group D, chemotherapy and both IFN-α and IFN-γ.
Abbreviations: NK, natural killer; NKT, natural killer T cell; IFN-α, interferon alpha; IFN-γ, interferon gamma.